Latest Period
Q4 2025
Security Snapshot
Core Laboratories Inc. /DE/ - Common Stock (CLB) Institutional Ownership
CUSIP: 21867A105
13F Institutional Holders and Ownership History from Q2 2020 to Q1 2026
Institutions Reporting
185
Shares (Excl. Options)
50,162,119
Price
$16.03
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- CLB on NYSE
- Shares outstanding
- 46,548,775
- Price per share
- $16.51
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 50,162,119
- Total reported value
- $804,175,358
- % of total 13F portfolios
- 0%
- Share change
- -1,265,490
- Value change
- -$17,755,175
- Number of holders
- 185
- Price from insider filings
- $16.51
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CLB - Core Laboratories Inc. /DE/ - Common Stock is tracked under CUSIP 21867A105.
- 185 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 185 to 51 between Q4 2025 and Q1 2026.
- Reported value moved from $804,175,358 to $53,496,572.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 185 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 21867A105?
CUSIP 21867A105 identifies CLB - Core Laboratories Inc. /DE/ - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 21867A105:
Significant Owners of Core Laboratories Inc. /DE/ - Common Stock (CLB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARIEL INVESTMENTS, LLC | 29% | +9.3% | $170,241,300 | +$14,539,859 | 13,773,568 | +9.3% | Ariel Investments, LLC | 30 Sep 2025 |
| BlackRock, Inc. | 16% | $85,107,722 | 7,261,751 | BlackRock, Inc. | 31 Mar 2025 | |||
| DISCIPLINED GROWTH INVESTORS INC /MN | 11% | -13% | $97,551,336 | -$15,159,620 | 5,166,914 | -13% | DISCIPLINED GROWTH INVESTORS INC /MN | 31 Dec 2025 |
| EARNEST PARTNERS LLC | 6.9% | $60,813,292 | 3,221,043 | EARNEST PARTNERS LLC | 31 Dec 2025 |
As of 31 Dec 2025, 185 institutional investors reported holding 50,162,119 shares of Core Laboratories Inc. /DE/ - Common Stock (CLB). This represents 108% of the company’s total 46,548,775 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Core Laboratories Inc. /DE/ - Common Stock (CLB) together control 98% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARIEL INVESTMENTS, LLC | 29% | 13,661,000 | -0.82% | 2.4% | $218,985,830 |
| BlackRock, Inc. | 15% | 7,153,543 | -1.4% | 0% | $114,671,291 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 11% | 5,166,914 | -13% | 1.6% | $82,825,631 |
| EARNEST PARTNERS LLC | 6.9% | 3,221,043 | -6% | 0.22% | $51,633,319 |
| VANGUARD GROUP INC | 6.6% | 3,079,882 | +1.1% | 0% | $49,370,508 |
| STATE STREET CORP | 4.4% | 2,041,740 | +3.3% | 0% | $32,729,092 |
| DIMENSIONAL FUND ADVISORS LP | 2.6% | 1,229,611 | +11% | 0% | $19,710,970 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,114,935 | +0.77% | 0% | $17,875,701 |
| T. Rowe Price Investment Management, Inc. | 2.2% | 1,042,208 | +15% | 0.01% | $16,707,000 |
| GOLDMAN SACHS GROUP INC | 1.8% | 845,251 | +185% | 0% | $13,549,373 |
| Fisher Asset Management, LLC | 1.7% | 774,979 | -6% | 0% | $12,422,912 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.6% | 737,550 | +12% | 0% | $11,822,927 |
| GENDELL JEFFREY L | 1.4% | 648,460 | +14% | 0.18% | $10,394,814 |
| CWA Asset Management Group, LLC | 1.3% | 622,453 | 0.36% | $9,977,922 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 1.2% | 551,115 | -1.5% | 0.03% | $8,834,373 |
| NORTHERN TRUST CORP | 1.2% | 543,493 | -5.9% | 0% | $8,712,192 |
| MORGAN STANLEY | 1% | 485,038 | -3.8% | 0% | $7,775,175 |
| UBS Group AG | 0.89% | 412,515 | +33% | 0% | $6,612,617 |
| Bank of New York Mellon Corp | 0.88% | 411,643 | +4.6% | 0% | $6,598,643 |
| AMERICAN CENTURY COMPANIES INC | 0.79% | 367,365 | +72% | 0% | $5,888,862 |
| VAN ECK ASSOCIATES CORP | 0.76% | 352,023 | +16% | 0% | $5,643,000 |
| MAC Alpha Capital Management, LP | 0.67% | 312,928 | 0% | 2.8% | $5,016,148 |
| PRINCIPAL FINANCIAL GROUP INC | 0.63% | 293,479 | +7.2% | 0% | $4,704,468 |
| Advisors Capital Management, LLC | 0.59% | 276,355 | +0.14% | 0.05% | $4,429,979 |
| WELLS FARGO & COMPANY/MN | 0.47% | 218,773 | -16% | 0% | $3,506,934 |
Institutional Holders of Core Laboratories Inc. /DE/ - Common Stock (CLB) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,186,949 | $53,496,572 | +$18,969,094 | $16.79 | 51 |
| 2025 Q4 | 50,162,119 | $804,175,358 | -$17,755,175 | $16.03 | 185 |
| 2025 Q3 | 51,201,255 | $632,858,492 | -$11,818,549 | $12.36 | 185 |
| 2025 Q2 | 52,229,758 | $601,703,431 | +$12,038,127 | $11.52 | 189 |
| 2025 Q1 | 50,873,441 | $762,455,278 | -$802,871 | $14.99 | 193 |
| 2024 Q4 | 50,808,445 | $879,519,256 | -$6,881,344 | $17.31 | 206 |
| 2024 Q3 | 51,038,534 | $945,722,085 | -$15,766,807 | $18.53 | 188 |
| 2024 Q2 | 51,687,236 | $1,048,489,480 | +$64,905,564 | $20.29 | 188 |
| 2024 Q1 | 48,615,242 | $830,350,000 | +$2,700,490 | $17.08 | 195 |
| 2023 Q4 | 48,448,673 | $855,372,251 | -$8,131,057 | $17.66 | 185 |
| 2023 Q3 | 48,377,118 | $1,161,324,514 | -$7,512,373 | $24.01 | 178 |
| 2023 Q2 | 48,704,673 | $1,132,671,034 | +$1,031,130,097 | $23.25 | 162 |
| 2023 Q1 | 4,365,179 | $96,252,170 | +$96,233,663 | $22.05 | 7 |
| 2022 Q4 | 913 | $18,507 | $20.27 | 1 | |
| 2022 Q3 | 913 | $12,307 | +$12,307 | $13.48 | 1 |
| 2022 Q2 | 0 | $0 | -$9,900 | $23.25 | 0 |
| 2022 Q1 | 313 | $9,900 | +$9,457 | $31.63 | 1 |
| 2021 Q4 | 14 | $312 | -$11,990 | $22.29 | 1 |
| 2021 Q3 | 552 | $15,318 | +$4,745 | $27.75 | 1 |
| 2021 Q2 | 381 | $14,840 | +$14,840 | $38.95 | 1 |
| 2020 Q4 | 0 | $0 | -$4,319 | $16.51 | 0 |
| 2020 Q3 | 283 | $4,319 | +$351 | $15.26 | 1 |
| 2020 Q2 | 260 | $5,283 | +$5,283 | $20.32 | 1 |